Current Developments in the Treatment of Postpartum Depression: Zuranolone.

At day 45, the difference among the groups was nominally significant ( P = .02). 38 Post hoc analyses indicate that patients who received zuranolone experienced positive effects on insomnia symptoms and their overall functional health and well-being, as reported by the patients themselves. 40 , 41 Patients who participated in the ROBIN study were randomly assigned to receive either zuranolone 30 mg or placebo, both taken once daily with an evening meal for a duration of 14 days.

also in 7,732 other papers